Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 12/20 | 0.79 |
| ▸ | ICMT | O60725 | 6/20 | 0.64 |
| ▸ | PPARG | P37231 | 2/20 | 0.54 |
| ▸ | PPARD | Q03181 | 2/20 | 0.54 |
| ▸ | PPARA | Q07869 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7953321 | 0.88 | PLA2G2A (1.00) | PLA2G2AICMTPPARGPPARDPPARA | |
| SCHEMBL2156634 | 0.85 | PLA2G2A (0.79) | PLA2G2A | |
| SCHEMBL7961585 | 0.84 | PLA2G2A (0.81) | PLA2G2AICMTPPARGPPARDPPARA | |
| SCHEMBL8298657 | 0.82 | PPARD (0.65) | PLA2G2AICMTPPARGPPARDPPARA | |
| SCHEMBL7952366 | 0.82 | PLA2G2A (1.00) | PLA2G2AICMTPPARGPPARDPPARA | |
| SCHEMBL7965400 | 0.82 | PLA2G2A (0.81) | PLA2G2A | |
| SCHEMBL7961582 | 0.81 | PLA2G2A (0.81) | PLA2G2AICMTPPARGPPARDPPARA | |
| SCHEMBL7963386 | 0.81 | PLA2G2A (0.86) | PLA2G2A | |
| SCHEMBL8926105 | 0.81 | PLA2G2A (0.70) | PLA2G2AICMT | |
| SCHEMBL7962123 | 0.81 | PLA2G2A (0.64) | PLA2G2AICMTPPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6252084-B1 | THERAPY FOR SEPSIS SHOCK | ELI LILLY AND COMPANY | 2001-06-26 | — | — | US | disclosed |
| EP-0620215-B1 | 1H-indole-3-acetamide derivatives as sPLA2 inhibitors | LILLY CO ELI (US) | 1999-08-18 | — | — | EP | disclosed |
| EP-0620215-A1 | 1H-indole-3-acetamide derivatives as sPLA2 inhibitors | ELI LILLY AND COMPANY (US) | 1994-10-19 | — | — | EP | disclosed |